A significant proportion of the current technological developments in pneumology originate from the various areas of information technology. The spectrum ranges from smartphone apps to be used in daily life or in patient care to the use of artificial intelligence in screening and early detection of diseases. The diagnostic accuracy of apps for symptom analysis is currently very limited. Research projects are performed on the integration of symptoms and functional parameters into early detection, but also on mobility measurements as a prognostic marker in COPD. Lung cancer screening using computed tomography represents a major challenge. Here, artificial intelligence can help radiologists to cope with huge amounts of data. However, the quality of the software depends on the sufficient training of the system. Technological developments shape all fields of pneumology. For diagnostic and interventional endoscopy, they offer improved biopsy techniques and microstructural imaging. Advances in lung function measurements allow the differentiated analysis of respiratory mechanical disorders, and they could be transferred to ventilation technology. The translation of basic findings about the lung microbiome into patient care may perspectively help to better understand and treat COPD exacerbations.
- Randerath, W.
- Dreher, M.
- Gompelmann, D.
- Held, M.
- Koczulla, R.
- Kohnlein, T.
- Rohde, G.
- Walscher, J.
- Watz, H.
- Steinkamp, G.
Keywords
- *Artificial Intelligence
- Early Detection of Cancer
- Humans
- Inventions
- *Lung Neoplasms/diagnosis/therapy
- Pulmonary Medicine/*trends
- Berlin Chemie, Boehringer Ingelheim, Chiesi, GSK, Hamilton, Heinen und
- Lowenstein, Intermune, Linde, Novartis, Pfizer, Philips Respironics, ResMed,
- Roche, Weinmann. Beratungshonorare von Almirall, Boehringer Ingelheim, Hamilton,
- Linde, Novartis, Pfizer, Philips Respironics, ResMed, Roche. Research Grants von
- Linde, Philips Respironics, ResMedRembert Koczulla erhielt Honorare fur
- Vortrage/Advisory Boards von Sanofi, Boehringer Ingelheim, Astra Zeneca, Chiesi,
- Novartis, Berlin Chemie, GSK, CSL Behring, Grifols, Streamed up, Schon Klinik,
- Produktunterstutzung von Novotec, Berater bei KaiaGernot Rohde erhielt Honorare
- fur Vortrage und Beratungstatigkeiten von Astra Zeneca, Boehringer Ingelheim,
- GSK, Novartis, Roche, Berlin Chemie, Grifols, Vertex, Pfizer, MSD, Chiesi, Bayer,
- Insmed, BMS, Sanofi, PulmonX.Winfried Randerath erhielt Honorare fur Vortrage und
- Beratertatigkeit von Bayer, Berlin Chemie, Boehringer Ingelheim, Heinen und
- Lowenstein, Novartis, Philips Respironics, ResMed.Gratiana Steinkamp erhielt
- Honorare fur medizinisch-wissenschaftliches Publizieren von Boehringer Ingelheim,
- InfectoPharm, Pari GmbH und Gilead.Julia Walscher erhielt Vortragshonorare und
- Reisekostenunterstutzungen von Boehringer Ingelheim und Roche.Henrik Watz erhielt
- Honorare fur Vortrage oder Beratungstatigkeit der Firmen Astra Zeneca, Boehringer
- Ingelheim, Bayer, BerlinChemie, Chiesi, GSK, Novartis, Takeda.
